Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
NCT07125391Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in ovarian cancer. Started Jun 2025; status: recruiting.
02
Drugs
propranolol
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07125391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125391.